cutaneous toxicity
Showing 1 - 25 of 7,955
Toxicity and Symptom Burden in Chronic Cancer Survivors With
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +7 more
- Assessment
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 6, 2022
Cutaneous Toxicity From ICI Therapy Trial in Baltimore (Immune checkpoint inhibitor (ICI))
Completed
- Cutaneous Toxicity From ICI Therapy
- Immune checkpoint inhibitor (ICI)
-
Baltimore, MarylandSidney Kimmel Comprehensive Care Center
May 19, 2021
Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Cutaneous Squamous Cell Carcinoma of the Head
Completed
- Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
- Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
- Gabapentin
- +6 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 8, 2021
Skin Health and Quality of Life in Patients Receiving
Not yet recruiting
- Lung Cancer
- +7 more
- EQ-5D-5L questionnaire
- +2 more
-
Roma, ItalyRoberto Iacovelli
May 17, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- Clinical Stage IV Cutaneous Melanoma AJCC v8
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 17, 2023
Chemotherapeutic Agent Toxicity, Pain, Peripheral Neuropathy Trial in Chicago (cryotherapy, questionnaire administration,
Terminated
- Chemotherapeutic Agent Toxicity
- +11 more
- cryotherapy
- +4 more
-
Chicago, IllinoisNorthwestern University
Aug 16, 2019
Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial in Lausanne (FLASH RT, Conventional RT)
Not yet recruiting
- Basal Cell Carcinoma
- Cutaneous Squamous Cell Carcinoma
- FLASH RT
- Conventional RT
-
Lausanne, Vaud, SwitzerlandCentre Hospitalier Universitaire Vaudois (CHUV)
Feb 13, 2023
Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)
Not yet recruiting
- Angiosarcoma
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 23, 2023
Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +3 more
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
May 17, 2023
Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United
Recruiting
- Folliculotropic Mycosis Fungoides
- +7 more
- Durvalumab
- +2 more
-
Duarte, California
- +3 more
Jan 12, 2023
Prevelance Of Cutaneous Disorders Among Heamatologic
Not yet recruiting
- Dermatologic Disorders With Heamatologic Malignancies Patients
- cbc ,u\s renalor hepatic function test if needed
-
Sohag, EgyptSohag university Hospital
Oct 25, 2023
Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and
Recruiting
- Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
- +4 more
- Cemiplimab
-
Houston, TexasM D Anderson Cancer Center
Jan 17, 2023
Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)
Recruiting
- Cutaneous Squamous Cell Carcinoma
- Advanced Cancer
- Cemiplimab
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous
Not yet recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +12 more
- Biopsy
- +8 more
- (no location specified)
Jun 8, 2023
Cutaneous Squamous Cell Carcinoma Trial in Amsterdam (Nivolumab, Ipilimumab)
Recruiting
- Cutaneous Squamous Cell Carcinoma
-
Amsterdam, Noord Holland, NetherlandsNKI-AVL
Oct 24, 2022
Pain, Postoperative Pain, Acute Pain Trial in Roma (PENG Block, Lateral Femoral Cutaneous Nerve Block, Wound Infiltration)
Not yet recruiting
- Pain
- +5 more
- PENG Block
- +2 more
-
Roma, ItalyUniversità Campus Biomedico
Jun 20, 2022
Squamous Cell Carcinoma Trial in Tampa (Afatinib 40 MG)
Recruiting
- Squamous Cell Carcinoma
- Afatinib 40 MG
-
Tampa, FloridaMoffitt Cancer Center
Dec 30, 2022
Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell
Recruiting
- Recurrent Adult T-Cell Leukemia/Lymphoma
- +3 more
- Cyclophosphamide
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 18, 2022
Leishmaniasis, Cutaneous Trial in Gharyan (Intralesional Sodium stibogluconate, Intralesional Cryotherapy, Intralesional
Recruiting
- Leishmaniasis, Cutaneous
- Intralesional Sodium stibogluconate
- +3 more
-
Gharyan, Select Region, Libyan Arab JamahiriyaDermatology department, Gharyan University Hospitals, Medical Co
Jan 31, 2023
Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,
Active, not recruiting
- Folliculotropic Mycosis Fungoides
- +7 more
- Extracorporeal Photopheresis
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Diffuse Cutaneous Systemic Sclerosis Trial in United States (Belumosudil)
Completed
- Diffuse Cutaneous Systemic Sclerosis
-
Los Angeles, California
- +4 more
Jan 5, 2023
Anesthesia, Conduction Trial in Belo Horizonte (Ropivacaine + saline solution, Saline solution + Ropivacaine)
Not yet recruiting
- Anesthesia, Conduction
- Ropivacaine + saline solution
- Saline solution + Ropivacaine
-
Belo Horizonte, Minas Gerais, BrazilHospital Odilon Behrens
Feb 27, 2023
Post-operative Pain, Anesthesia, Local Trial in Montreal (Para-Sartorial Compartments (PACS) Block + Femoral Triangle Block
Not yet recruiting
- Post-operative Pain
- Anesthesia, Local
- Para-Sartorial Compartments (PACS) Block + Femoral Triangle Block (FTB) + infiltration between popliteal artery and capsule of the knee block (IPACK)
- Femoral Triangle Block (FTB) + infiltration between popliteal artery and capsule of the knee block (IPACK)
-
Montreal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal (CHUM)
Sep 8, 2023
Leishmaniasis, Cutaneous Trial in Medellín (Arnica Tincture)
Not yet recruiting
- Leishmaniasis, Cutaneous
- Arnica Tincture
-
Medellín, Antioquia, ColombiaProgram for Research and Control in Tropical Diseases - PECET
Jun 4, 2022